Cresset Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cresset Asset Management's BMY Position: Q2 2026 in Review
Cresset Asset Management increased its Bristol-Myers Squibb (BMY) stake by 1.3% in Q2 2026, buying an estimated $299K and bringing the position to 417,663 shares worth $24.1M. The position accounts for 0.09% of the portfolio, ranked #148.
Cresset Asset Management first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $30M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cresset Asset Management held 417,663 shares of Bristol-Myers Squibb worth $24.1M as of Q2 2026.
- Cresset Asset Management bought 5,199 Bristol-Myers Squibb shares in Q2 2026, an estimated $299K.
- Bristol-Myers Squibb made up 0.09% of Cresset Asset Management's portfolio in Q2 2026, its #148 holding.
- Cresset Asset Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's Bristol-Myers Squibb position peaked at $30M in Q2 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.